JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2024, 73(3):156-162 | DOI: 10.36290/csf.2024.024

Current pharmacotherapy of rosacea

Magdalena Ryšavá1, Renata Žáková2
1 Pracoviště klinické farmacie, Nemocnice Milosrdných bratří, Brno
2 Úsek klinické farmacie, Lékárna Nemocnice Jihlava

Up to one-fifth of patients in GP surgeries have skin diseases. One of the most serious is rosacea, which can significantly reduce quality of life and increase the incidence of psychosocial disorders (depression, anxiety, social isolation) in patients with this disease. The prevalence of the disease is reported to be around 10 %. Successful dermatological treatment of rosacea is a complex process involving a correct diagnostic assessment, choosing an appropriate therapeutic approach for the patient. It is mainly guided by the severity of symptoms, the psychological impact on the patient and the compliance to treatment. Primarily, provocative factors should be reduced, and dermocosmetics available in the pharmacy can be used as a supportive and complementary treatment. The results of pharmacological treatment are often unsatisfactory.

Keywords: rosacea, facial erythrosis, dermatosis, dermocosmetics.

Accepted: September 23, 2024; Published: October 8, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryšavá M, Žáková R. Current pharmacotherapy of rosacea. Čes. slov. farm. 2024;73(3):156-162. doi: 10.36290/csf.2024.024.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 8.10.2025

    References

    1. Harper J. Rosacea Linked To A Higher Risk Of Parkinson's And Alzheimer's Diseases. In: mayoclinic.org (Internet). 2016. (cited 2024-04-05). Available from: https://www.rosacea.org/rosacea-review/2016/summer/rosacea-linked-to-a-higher-risk-of-parkinsons-and-alzheimers-diseases.
    2. Egeberg A, Hansen RP, Gislason HG et al. Patients with rosacea have increased risk of dementia. Ann Neurol. 2016;79(6): 921-928. Go to original source... Go to PubMed...
    3. Choi D, Choi S, Park SM et al. Association of Rosacea With Cardiovascular Disease: A Retrospective Cohort Study. J Am Heart Assoc. 2021;10(19):1-10. Go to original source... Go to PubMed...
    4. Lazaridou E, Korfitis CH, Kemanetzi CH et al. Rosacea and Helicobacter pylori: links and risks. Clin Cosmet Investig Dermatol. 2017;10:305-310. Go to original source... Go to PubMed...
    5. Jørgensen AR, Egeberg A, Gideonsson R et al. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2017;31(12):2010-2015. Go to original source... Go to PubMed...
    6. Yang X. Relationship between Helicobacter pylori and Rosacea: review and discussion. BMC Infect Dis. 2018;18(1). Go to original source... Go to PubMed...
    7. Kim JH, Min JH; Jo YW et al. Association Between Acid-Suppressive Drugs and Risk of Rosacea: Retrospective Study Using the Korean National Health Insurance Service-National Sample Cohort. J Korean Med Sci. 2023;38(47). Go to original source... Go to PubMed...
    8. Mills CM, Marks R. Environmental factors influencing rosacea. Clin Exp Dermatol. 1996;21(2):172-3. Go to original source...
    9. Geng RSQ, Bourkas AN, Mufti A et al. Rosacea: Pathogenesis and Therapeutic Correlates. J surg med. 2024;28(2):178-189. Go to original source... Go to PubMed...
    10. Nevoralová Z. Léčba akné a růžovky v těhotenství. Remedia. 2018;(28)6;590-595.
    11. Krajsová I. Úspěšná terapie kožních onemocnění vyžaduje komplexní přístup. Remedia. 2017; 27(3):216
    12. Rosacea (Internet). Mayo Clinic Health Library; c2024 (cited 2024-04-05). Available from: https://www.mayoclinic.org/diseases-conditions/rosacea/diagnosis-treatment/drc-20353820.
    13. Pánková R. Rosacea. Dermatol praxi. 2017;11(1):6-11. Go to original source...
    14. Ludmann P. Rosacea: Overview. In: aad.ord (Internet). 2024. (cited 2024-04-05). Available from: https://www.aad.org/public/diseases/rosacea/what-is/overview.
    15. Benáková N. Rosacea. Čes-slov Derm. 2018;93(2):79.
    16. Kafka V. Ekzémy, Rosacea. In: Akademie Pierre Fabre Dermo-Cosmétique: 55. cyklus. Feb 2024. Brno.
    17. Rosacea (růžovka) a kuperóza - Poznejte příznaky onemocnění včas a najděte řešení. (Internet). 2024. (cited 2024-05-07). Available from: https://www.eucerin.cz/o-kuzi/indikace/rosacea. Go to original source...
    18. Gallucio G, D'Onghia M, Malvaso D et al.: A Phenotype-Based Therapeutic Approach. Cosmetics. 2024;11(1). Go to original source...
    19. Semenescu I, Similie D, Diaconeasa Z et al. Recent Advances in the Management of Rosacea through Natural Compounds. Pharmaceuticals. 2024;17(2):212. Go to original source... Go to PubMed...
    20. Jiawen Z, Peiyu J, Lei Sheng et al. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages. Front. immunol. 2021;12. Go to original source... Go to PubMed...
    21. Assiri A, Hobani AH, AlKaabi HA et al. Efficacy of Low-Dose Isotretinoin in the Treatment of Rosacea: A Systematic Review and Meta-Analysis. Cureus. 2024;16(3). Go to original source... Go to PubMed...
    22. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol. 1999;46(6):961-965. Go to original source... Go to PubMed...
    23. Reinholz M., Tietze JK, Kilian K et al. Rosacea - S1 Guideline. JDDG. 2013;11(8):768-780. Go to original source...
    24. Ihrisky SA. Rozacea - současný pohled. Čes-slov Derm. 2018;93(5):163-173.
    25. Pelle MT, Crawford GH, RAWFORD, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51(4):499-512. Go to original source... Go to PubMed...
    26. Majer LE, Helfrich YR. Rosacea: Pathogenesis, clinical features, and diagnosis. In: UpToDate. 2022, 03-2024. Dostupné z: https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis?sectionName=CLINICAL+FEATURES & search=rosacea & topicRef=16632 & anchor=H432867 & source=see_link#H432867. (cit. 2024-04-05).
    27. Maier L. E. Management of rosacea. Online. UpToDate. 2022, 03-2024. Dostupné z: https://www.uptodate.com/contents/management-of-rosacea?search=rosacea & source=search_result & selectedTitle=2%7E124 & usage_type=default & display_rank=1. (cit. 2024-04-05).
    28. Bamford JT, Elliott BA, Haller IV. Tacrolimus effect on rosacea. J Am Acad Dermatol. 2004;50(1):107-8. Go to original source... Go to PubMed...
    29. Nevoralová Z. Léčba Rosacey. Remedia. 2017; 27(3):219-225.
    30. Sobolewska B, Doycheva D, Deuter C et al. Treatment of ocular rosacea with once-daily low-dose doxycycline. Cornea. 2014;33(3):257-60. Go to original source... Go to PubMed...
    31. Bloom BS, Payongayong L, Mourin A, Goldberg DJ. Impact of intradermal abobotulinumtoxinA on facial erythema of rosacea. Dermatol Surg. 2015;41(1):9-16. Go to original source... Go to PubMed...
    32. Dwayebová R. Local therapy of inflammatory (papulopustular) lesions of rosacea in adult patients. Dermatol praxi. 2018;12(4):164-166. Go to original source...
    33. Slonková V. Rosacea a dermatitis perioralis. Čes-slov Derm. 2008;84(4):183-193.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.